LCK Global Kedaton Tbk. vs Merck Tbk. — how do they compare? LCK Global Kedaton Tbk. trades at Rp111 (market cap 107B, 39.11M 24h volume), while Merck Tbk. trades at Rp3,840 (market cap 1.7T, 37.6K 24h volume). The key difference: Merck Tbk. is far larger — about 15.9× LCK Global Kedaton Tbk.'s market cap, and LCK Global Kedaton Tbk. is more actively traded (39.11M versus 37.6K). Which is the better fit depends on your goals.
| LCKM | MERK | |
|---|---|---|
Market Cap | 107B | 1.7T |
Volume | 39.11M | 37.6K |
Lot | 391.08K | 376 |
Turnover | 4.36B | 144.47M |
Average Price | 111.56 | 3,842.23 |
Value | 4.36B | 144.47M |
Indicative Equilibrium Price | 111 | 3,840 |
Indicative Equilibrium Volume | 3.23K | 7 |
Trailing returns across standard periods
Latest headlines on both assets
PT LCK Global Kedaton (the "Company") was established on July 31, 2013 based on Deed of Establishment no. 44 made before Notary Sahat Simanungkalit, SH, M.Kn
Read more on LCKM →PT Merck Tbk (the Company) is domiciled in Indonesia and located at Jl. TB Simatupang No. 8, Pasar Rebo, East Jakarta, was established in framework of Law No. 1 of 1967 and Law No. 11 of 1970 on foreign capital investment by deed of notary public Eliza Pondaag, SH dated 14 October 1970 No. 29. PT Merck Indonesia is a member of the Merck International Group. The company produces pharmaceutical products with production facility in East Jakarta. It commenced its operation in 1974 in manufacturing medical products, such as Songobian and Neurobion.
Read more on MERK →